Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Sol-Gel Technologies Ltd.
Sponsor

Sol-Gel Technologies Ltd.

7 Golda Meir, 7403650

About the sponsor

Clinical research is centered on Gorlin syndrome, with attention to preventing basal cell carcinomas on the face and addressing the dermatologic burden associated with this inherited condition.

  • Facial basal cell carcinoma prevention
  • Inherited cancer predisposition
  • Dermatologic oncology

The sponsor’s activity reflects a focused interest in skin cancer management within a rare genetic disorder affecting the face and other sun-exposed areas.

About Specializations

Sol-Gel Technologies Ltd. runs clinical trials in conditions such as Basal cell naevus syndrome, among others.

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

1 clinical trial

Basal cell naevus syndrome

Not recruiting
Investigational
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Patidegib Hydrochloride Isopropanolate
  • Sponsor:Sol-Gel Technologies Ltd.

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.